Editorial

DOI: 10.4244/EIJ-E-22-00053

Coronary calcification: you have to crack a few eggs to make an omelette

Manel Sabaté1, MD, PhD

Coronary calcification represents an advanced stage of the inflammatory atherosclerosis process1. From a clinical point of view, it is associated with the elderly and chronic comorbidities such as diabetes mellitus or chronic kidney disease23. Typically, in these clinical contexts, revascularisation outcomes from percutaneous coronary intervention are worse than those in younger and less comorbid patients45.

Currently, the ageing of the population is leading to an increase in the number of comorbid patients with calcified coronary arteries needing revascularisation6. Moreover, in this subset of patients, the selected revascularisation type is most often percutaneous, given the less invasive nature of the procedure compared to coronary artery bypass graft. As a result, most interventional cardiologists have to deal with complex, high-risk percutaneous coronary intervention (CHIP) procedures in everyday practice. The treatment of diffuse calcified lesions falls entirely within this category of CHIP procedures that require the use of specific tools to successfully perform the procedures.

In this issue of EuroIntervention, Rheude et al investigate the long-term outcomes (up to 10 years) of patients treated with different stent platforms according to the degree of coronary artery calcification7. In a pooled analysis involving 4,953 patients (6,924 lesions), the authors found an incremental risk of events according to the degree of calcification. Interestingly, in patients with severe calcification, no differences in event rates were observed between permanent polymer, biodegradable polymer and polymer-free drug-eluting stent platforms. At 10 years, the rates of clinical events in patients with severe calcification nearly doubled, including mortality, target lesion revascularisation, myocardial infarction and stent thrombosis, compared to those without angiographic calcification. Remarkably, 10-year mortality and target lesion revascularisation rates in the group with heavily calcified lesions nearly reached one in two and one in three, respectively.

From a procedural point of view, despite being highly complex lesions (high rates of type B2/C lesions, chronic total occlusions and ostial locations) with long lesion and stent lengths, the use of rotational atherectomy was anecdotal even in heavily calcified patients (3%). Lesion/vessel preparation is essential to ensure adequate stent expansion. Stent underexpansion is typically related to an increased risk of stent thrombosis and restenosis8. In fact, in the present study, stent thrombosis was three times higher in severe calcified lesions (3.6% vs 1.3% in non-calcified vessels). We must acknowledge that some of the current balloon-based techniques and the new ablative tools (e.g., orbital atherectomy) were not available on the market a decade ago. However, others, such as the above-mentioned rotablation or scoring/cutting balloons, were available and might have eventually impacted long-term prognoses if used more frequently in this heavily calcified cohort of patients9. Similarly, the rate of intravascular imaging (IVI) use was not reported. IVI has been demonstrated to improve outcomes and is currently recommended in CHIP procedures9. Imaging may help recognise the calcium disposition, select the debulking technique, assess the response to lesion preparation and optimise stent implantation. In this regard, several algorithms have been developed to help in the decision-making process of the treatment of calcified lesions10.

Despite the above-described limitations, the results of this study will lay the groundwork for future trials aimed at improving outcomes in CHIP procedures.

Conflict of interest statement

The author has no conflicts of interest to declare.


References

Volume 18 Number 14
Feb 20, 2023
Volume 18 Number 14
View full issue


Key metrics

On the same subject

Clinical Research

10.4244/EIJ-D-21-00504 Mar 18, 2022
Prevalence, predictors, and outcomes of in-stent restenosis with calcified nodules
Tada T et al
free

10.4244/EIJV11I12A260 Mar 18, 2016
Bioresorbable scaffolds for calcified lesions: not a free lunch!
Capodanno D
free

CLINICAL RESEARCH

10.4244/EIJ-D-17-00962 Apr 6, 2018
A new optical coherence tomography-based calcium scoring system to predict stent underexpansion
Fujino A et al
free

Clinical research

10.4244/EIJ-D-21-00976 Oct 21, 2022
Prevalence and outcomes of stent thrombosis with in-stent calcified nodules: substudy from the REAL-ST registry
Takahashi Y et al
free
Trending articles
281.38

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
243.2

State of the art

10.4244/EIJ-D-21-01117 Sep 20, 2022
Recanalisation of coronary chronic total occlusions
Di Mario C et al
free
208.35

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.7

Translational research

10.4244/EIJ-D-21-00824 May 15, 2022
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation
Toth GG et al
free
167.05

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
151.03

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
118

Translational research

10.4244/EIJ-D-22-00718 Jun 5, 2023
Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds
Seguchi M et al
110.35

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved